Lista de obras - A Reuben - Dominio Público Uruguay

18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer

artículo científico publicado en 2020

A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma

artículo científico publicado en 2019

A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.

artículo científico publicado en 2018

An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition

artículo científico publicado en 2017

Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

artículo científico publicado en 2018

B cells and tertiary lymphoid structures promote immunotherapy response

artículo científico publicado en 2020

Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies

scientific article published on 21 October 2019

Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma

article

Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab.

artículo científico publicado en 2017

Comprehensive T cell repertoire characterization of non-small cell lung cancer

artículo científico publicado en 2020

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

artículo científico publicado en 2020

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

scientific article published on 01 November 2018

Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas

artículo científico publicado en 2021

Evolution of genomic and T cell repertoire heterogeneity of malignant pleural mesothelioma under dasatinib treatment

scientific article published on 14 August 2020

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.

artículo científico publicado en 2017

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

artículo científico publicado en 2017

Immuno-genomic landscape of osteosarcoma

scientific article published on 21 February 2020

Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.

artículo científico publicado en 2017

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

scientific article published on 11 September 2020

Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases

artículo científico publicado en 2019

Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma

scientific article published on 05 July 2019

Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy

scientific article published on 07 January 2020

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

artículo científico publicado en 2018

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

artículo científico publicado en 2021

Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer

scientific article published on 01 April 2020

Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.

artículo científico publicado en 2017

Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively

artículo científico publicado en 2020

Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer

artículo científico publicado en 2019

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

artículo científico publicado en 2017

Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

artículo científico publicado en 2018

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i>-mutated melanoma

artículo científico publicado en 2021

Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma

artículo científico publicado en 2020

The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics

artículo científico publicado en 2021

Lista de obras de A Reuben

18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer

A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma

A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.

An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition

Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

B cells and tertiary lymphoid structures promote immunotherapy response

Combination anti-CTLA-4 plus anti-PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies

Combined Analysis of Antigen Presentation and T-cell Recognition Reveals Restricted Immune Responses in Melanoma

Comparative immunologic characterization of autoimmune giant cell myocarditis with ipilimumab.

Comprehensive T cell repertoire characterization of non-small cell lung cancer

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas

Evolution of genomic and T cell repertoire heterogeneity of malignant pleural mesothelioma under dasatinib treatment

Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.

Immuno-genomic landscape of osteosarcoma

Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases

Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma

Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer

Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.

Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively

Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in <i>Braf</i>-mutated melanoma

Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma

The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics